BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
HIV infection
,
Breast
,
Laryngoscope
,
Lipopolysaccharide
,
rs3825942
,
CXCL2
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
antiplatelet drugs
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
ATF3
FOS
EGR1
PDE4B
IFIT1
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
organic cyclic compound binding
heterocyclic compound binding
organic cyclic compound metabolic process
regulation of nitrogen compound metabolic process
DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Pulmonary artery smooth muscle gene expression before or after exposure to S-nitrosoglutathione
Expression analysis of ER stress response in C. elegans
Effect of synthetic dietary triglycerides on liver of WT and PPARα-null mice
Liver Pharmacology and Xenobiotic Response Repertoire
Liver from mice fed high-calorie diet or high calorie diet + resveratrol
Explore Curated Studies Results
Literature
Most Relevant Literature
The pharmacology of antiplatelet agents for primary, secondary, and tertiary prevention of ischemic …
A new score for predicting intracranial hemorrhage in patients using antiplatelet drugs.
Effects of preceding antiplatelet agents on severity of ischemic stroke in patients with a history o…
Antiplatelet drugs: Potential therapeutic options for the management of neurodegenerative diseases.
Antiplatelet agents for chronic kidney disease.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Type 2 Diabetes With Antiplatelet Drugs
Long-term MOno-Antiplatelet Drug Strategy After PerCutanEous CoronAry InterveNtion
Pharmacokinetics of Antiplatelet Drugs in Diabetic pAtients
Desmopressin for Reversal of Antiplatelet Drugs in Stroke Due to Haemorrhage
Evaluation of Antiplatelet Drug Resistance in Taiwanese With VASP & Platelet Mapping ™ Assay
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ